Today’s special

BGG Relaunches ApplePhenon With Four Clinical Studies, Targets GLP-1 Users

BGG relaunched ApplePhenon last year with four clinical studies on weight, LDL cholesterol and glucose, and aims it at GLP-1 muscle loss.